359 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Sensible Money LLC

Sensible Money LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 359 shares of the healthcare conglomerate’s stock, valued at approximately $210,000.

A number of other hedge funds have also made changes to their positions in UNH. Beese Fulmer Investment Management Inc. lifted its holdings in UnitedHealth Group by 1,262.2% during the 1st quarter. Beese Fulmer Investment Management Inc. now owns 20,623 shares of the healthcare conglomerate’s stock worth $10,202,000 after buying an additional 19,109 shares during the last quarter. Marion Wealth Management increased its stake in UnitedHealth Group by 1.8% during the first quarter. Marion Wealth Management now owns 4,733 shares of the healthcare conglomerate’s stock valued at $2,341,000 after purchasing an additional 82 shares during the last quarter. Atlas Brown Inc. boosted its holdings in shares of UnitedHealth Group by 1.4% in the 1st quarter. Atlas Brown Inc. now owns 1,682 shares of the healthcare conglomerate’s stock valued at $832,000 after buying an additional 24 shares during the period. Emprise Bank acquired a new stake in UnitedHealth Group during the first quarter worth about $1,908,000. Finally, Rise Advisors LLC boosted its stake in UnitedHealth Group by 225.8% in the first quarter. Rise Advisors LLC now owns 694 shares of the healthcare conglomerate’s stock valued at $344,000 after acquiring an additional 481 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $561.50 on Thursday. The stock has a market capitalization of $518.50 billion, a P/E ratio of 37.88, a P/E/G ratio of 1.69 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The business’s fifty day moving average is $584.21 and its two-hundred day moving average is $532.84. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the company posted $6.56 EPS. UnitedHealth Group’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.50%. UnitedHealth Group’s payout ratio is presently 55.70%.

Analyst Ratings Changes

A number of research firms recently issued reports on UNH. Bank of America reduced their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday. KeyCorp initiated coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. TD Cowen boosted their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday. Finally, Truist Financial reaffirmed a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday. One investment analyst has rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $615.16.

Get Our Latest Stock Report on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.